Address
Oxford Finance LLC
San Diego, CA
United States
Oxford Finance LLC
Palo Alto, CA
United States
Website
VCID: 82556
Profile
Corporate information
Official name
Oxford Finance Limited Liability Company
Registration country
Investment activity status
Active investor
Company type
Provider of capital exclusively to life sciences and healthcare services companies worldwide.Overview
Oxford Finance is a specialty finance firm providing senior secured loans to public and private life sciences and healthcare services companies worldwide. For over 20 years, Oxford has delivered flexible financing solutions to its clients, enabling these companies to maximize their equity by leveraging their assets. In recent years, Oxford has originated over $6 billion in loans, with lines of credit ranging from $5 million to $150 million. Oxford is headquartered in Alexandria, Va., with additional offices in San Diego, Calif.; Palo Alto, Calif.; and the greater Boston and New York City areas.
Investments
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Avanir Pharmaceuticals Inc A biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. |
United States | 1 Jun 2012 | Debt Initial investment. Round participant. Active |
|
|
|
Ceptaris Therapeutics Inc Specialty pharmaceuticals company. |
United States | 1 Feb 2012 | Debt Initial investment. Round participant. Active |
|
|
|
Tranzyme Pharma Drug discovery and development, focused on gastroenterology indications |
United States | 1 Feb 2012 | Debt Initial investment. Round participant. Active |
|
|
|
TearScience Inc Developer of a diagnostic and treatment devices targeted at the root cause of the majority of dry eye cases. |
United States | 1 Oct 2011 | Debt Active |
|
|
|
AirXpanders A medical device company that has developed the AeroForm tissue expander. |
United States | 1 Mar 2011 | Venture Initial investment. Round participant. Active |
|
|
|
NeoVista Inc |
United States | 1 Mar 2011 | Debt Initial investment. Round participant. Active |
|
|
|
Intuity Medical Inc |
United States | 1 Feb 2011 | N/A Initial investment. Round participant. Active |
|
|
|
MediciNova Inc Focuses on acquiring and developing novel, small-molecule therapeutics for the US market. |
United States | 1 May 2010 | Debt Initial investment. Round participant. Active |
|
|
Zogenix Inc A pharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system disorders and pain. |
United States | 1 Oct 2009 | Series B Initial investment. Round participant. Active |
|
|
|
Tengion Inc A leading regenerative medicine company. |
United States | 1 Oct 2007 | Series C Initial investment. Round participant. Active |
|
|
|
SkinMedica Inc Engages developing, acquiring, and commercializing prescription and non-prescription skin care products that improve the appearance of skin. |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Tethys Bioscience Inc |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Vitae Pharmaceuticals Inc Drug discovery company developing optimized drugs using proprietary computational drug design platform. |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Endocyte Inc Folate-based cancer and autoimmune disease therapies |
United States | N/A Initial investment. Round participant. Active |
||
|
|
EUSA Pharma Inc Trans-Atlantic specialty pharmaceutical company which focuses on oncology and critical care |
United States | N/A Initial investment. Round participant. Active |
||
|
NanoString Technologies Inc A life sciences company, markets solutions for detecting and counting large sets of target molecules in biological samples for researchers. |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Innovative Spinal Technologies Inc Spine technology company. |
United States | N/A Initial investment. Round participant. Active |